𝔖 Bobbio Scriptorium

✦ LIBER ✦

A Comprehensive Study of Clinical Biomarkers, Use of Inotropic Medications and Fluid Resuscitation in Newborns with Persistent Pulmonary Hypertension

✍ Scribed by Mydam, Janardhan; Zidan, Marwan; Chouthai, Nitin Shashikant

Book ID: 127181690
Publisher: Springer
Year: 2014
Tongue: English
Weight: 212 KB
Volume: 36
Category: Article
ISSN: 0172-0643
DOI: 10.1007/s00246-014-0992-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extracorporeal membrane oxygenation and

Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: A prospective randomized study: P.P. O'Rourke R.K. Crone, J.P. Vacanti, et al. Pediatrics 84:957–963, (December), 1989

✍ Jeffrey L. Zitsman 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 130 KB

A Randomized, Open-Label, 3-Way Crossove

A Randomized, Open-Label, 3-Way Crossover Study to Demonstrate Bioequivalence of Sildenafil Powder for Oral Suspension With Tablets Used Commercially and in Clinical Studies for the Treatment of Pulmonary Arterial Hypertension

✍ Gao, X.; O'Gorman, M.; Cook, J.; Shi, H.; LaBadie, R. R. 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 260 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB